AstraZeneca PLC is 168.5x more valuable than Biohaven Ltd. by market capitalization ($286.27 B vs $1.70 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BHVN | AZN |
|---|---|---|
| Market cap | $1.70 B | $286.27 B |
| US-listed rank | #2232 | #47 |
| Net income (latest FY) | -$738.82M | - |
| SEC filings | 265 | 1,004 |
AstraZeneca PLC is 168.5x more valuable than Biohaven Ltd. by market capitalization ($286.27 B vs $1.70 B).
Full pages: Biohaven Ltd. and AstraZeneca PLC, or browse the full rankings.